Netherlands · Investor

EQT Life Sciences

Last cheque observed Oct 2026; 60 cheques on record.

Deploying nowVC firm

Series ASeries BGrowthVenture Capital & Private Equity

Deploying now
80%of best year16cheques in 12 months, 60 on record
Since the last cheque12days00hrs00min00sec
Median round$50MRounds led2 of 60Sole investor3 roundsMostly inNetherlands, 20%
Pitch EQT Life Sciences

EQT Life Sciences highlights

  1. 01

    16 cheques in the last 12 months

  2. 02

    Mostly Series B and Series A: 56% of its rounds

  3. 03

    Sole investor in 3 rounds, median $57M

What they do

Type
VC firm (from a list, unverified)
Cheque size
Not stated
Stages
Series ASeries BGrowth
Sectors
Venture Capital & Private Equity
Based in
Amsterdam, Netherlands
Cold pitches
Not stated

The record

Every round we can evidence, newest first60 appearances

  1. 2026

    14 rounds

  2. Oct
    NouscomSeries D · CH · Revelation Partners$135MWith 14 others
  3. Sept
    Neurent MedicalDebt · IE · Claret Capital Partners$29MWith 6 others
  4. Sept
    AstronauTxGrant · GB$1.2MWith 2 others
  5. Aug
    Vaderis TherapeuticsSeries B · CH · Firms' own news pages$152MWith 8 others
  6. Jul
    XeltisNL · Ysios Capital$23MWith 5 others
  7. Jun
    RQ BioSeries A · GB · Frazier Life Sciences$115MWith 7 others
  8. Apr
    OnwardNL$48MWith 1 other
  9. Mar
    AviadoBioVenture · GBUndisclosedWith 1 other
  10. Mar
    Egle TherapeuticsGrant · FR$9.4MWith 2 others
  11. Feb
    EvommuneUS$125MWith 5 others
  12. Jan
    ExcivaSeries B · DE$59MWith 1 other
  13. Jan
    Tenpoint TherapeuticsDebt · GB$150MWith 4 others
  14. Jan
    ViCentraSeries D · NL$13MWith 1 other
  15. Jan
    Kinaset TherapeuticsSeries B · US$103MWith 3 others
  16. 2025

    17 rounds

  17. Dec
    FoRx TherapeuticsSeries A · CH$50MWith 1 other
  18. Nov
    Artios PharmaSeries D · GB$115MWith 5 others
  19. Oct
    OnwardNL$58MWith 2 others
  20. Oct
    TubulisSeries C · DE$401MWith 4 others
  21. Sept
    ViCentraGrowth · NL · Silicon Canals$85MWith 4 others
  22. Aug
    CytedSeries B · GB$44MWith 3 others
  23. Aug
    SNIPRSeries B · DK · Firms' own news pages$41MWith 5 others
  24. Jul
    Neuros MedicalSeries D · US$56MWith 1 other
  25. Jun
    Mosanna TherapeuticsSeries A · CH · Silicon Canals$80MLed
  26. Jun
    Splice BioSeries B · ES$135MWith 2 others
  27. Apr
    AvidicureSeed · NL$50MWith 2 others
  28. Apr
    XilisVenture · US$19MWith 5 others
  29. Mar
    PerfuzeGrowth · IE · Seroba Life Sciences$24MLed
  30. Feb
    XyloCor TherapeuticsSeries B · US · Crunchbase News$68MWith 2 others
  31. Feb
    DNA ScriptGrant · FR$4.7MWith 5 others
  32. Feb
    VarmXVenture · NL$16MWith 1 other
  33. Jan
    Atalanta TherapeuticsSeries B · US$97MWith 1 other
  34. 2024

    12 rounds

  35. Dec
    Noema PharmaSeries B · CH$147MWith 3 others
  36. Dec
    NUA SurgicalSeries A · IE$6.9MWith 2 others
  37. Nov
    ATB TherapeuticsSeries A · BE$57MSole investor
  38. Oct
    AgomAb TherapeuticsSeries D · BE$89MWith 4 others
  39. Oct
    AviadoBioVenture · GB$20MWith 1 other
  40. Sept
    PanteraSeries A · US$110MWith 4 others
  41. Aug
    ImCheck TherapeuticsGrant · FR$22MWith 6 others
  42. Aug
    Shinobi TherapeuticsSeries A · US$68MWith 2 others
  43. Jun
    Vico TherapeuticsSeries B · NL · Seroba Life Sciences$12MWith 12 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

Named by the firm itself, on a filing, its Form ADV or its company registration8 named

BEBarry Eamon BreenChief Compliance OfficeriForm ADV
BMBrian Michael FogartyDirectoriForm ADV
HSHenry SteinbergDirector, PresidentiForm ADV
JPJohn Peter LloydDirector, Chief Financial OfficeriForm ADV
JNJosefin Nowen WirkkalaDirectoriForm ADV
MJMatthew Joseph BrodnickDirector, Chief Investment OfficeriForm ADV
PJPatrick John CordesDirectoriForm ADV
PSPiyush SinghviDirectoriForm ADV

We also hold 5 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

What the register says

From the firm's own filings with the SEC, which it must file accurately by law

$51Bassets it manages, 2 advisers combinedOct 2026
8+funds on filenumbered funds in its name
Registeredinvestment adviserfull reporting to the SEC
Legal name
EQT REAL Estate, LLC
SEC number
CRD 161935

Funds on its Form ADV

13 private funds, $17B in gross assets · filed Oct 2024

  1. Exeter Industrial Value Fund V, L.P.Real estate60 investors$5.7B
  2. Exeter Industrial Core Fund III, L.P.Real estate$2.9B
  3. Exeter Europe Industrial Core Fund S.c.sp.Real estate7 investors$2.0B
  4. EQT Exeter Industrial Core-Plus Fund IV L.P.Real estate6 investors$2.0B
  5. Exeter Core Industrial CLUB Fund II, L.P.Real estate10 investors$1.8B
  6. Exeter Europe Logistics Value Fund IV, S.c.sp.Real estate36 investors$1.5B
  7. EQT Exeter Industrial Value Fund VI, L.P.Real estate77 investors$987M
  8. Exeter Industrial Value Fund IV, L.P.Real estate51 investors$170M
  9. Exeter Office Value Fund, L.P.Real estate3 investors$113M
  10. EM P28 Opportunities Fund, L.P.Real estate26 investors$107M

And 3 more on the filing.

Who they invest alongside

The investors most often in the same rounds as EQT Life Sciences. A count of rooms they were both in, not a relationship either has claimed.

Recently backed

The latest companies EQT Life Sciences put money into.

Quick answers about EQT Life Sciences

What does EQT Life Sciences invest in?

EQT Life Sciences invests most often at Series B and Series A (56% of the rounds on record), in sectors such as Venture Capital & Private Equity.

How active is EQT Life Sciences?

60 investments on record, 16 of them in the last 12 months, and it led 2. The most recent was in Oct 2026.

What has EQT Life Sciences invested in recently?

Its most recent investments on record: Nouscom (Series D, Oct 2026), Neurent Medical (Debt, Sept 2026) and AstronauTx (Grant, Sept 2026).

How big are EQT Life Sciences's cheques?

The median round it joins is $50M.

Does EQT Life Sciences lead rounds?

Sometimes: it led 2 of its 60 investments on record (3%).

Where does EQT Life Sciences invest?

Most of the companies it backs are in the Netherlands (20%), the United States (20%) and the United Kingdom (18%).

Is EQT Life Sciences investing now?

Yes: it is actively investing, with 16 investments in the last 12 months.

Who does EQT Life Sciences invest alongside?

Most often Andera Partners (13 rounds together), EQT (7 rounds together) and Bpifrance (6 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it